Could albumin be a biomarker to monitor the effect of intravenous immunoglobulin on Guillain-Barré syndrome?: In reply

2017-07-01

JAMA Neurology , Volume 74 - Issue 7 p. 872

Additional Metadata
Persistent URL	doi.org/10.1001/jamaneurol.2017.0566, hdl.handle.net/1765/101168
Journal	JAMA Neurology
Organisation	Department of Immunology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Fokkink, W.-J., & Jacobs, B. C. (2017). Could albumin be a biomarker to monitor the effect of intravenous immunoglobulin on Guillain-Barré syndrome?: In reply. JAMA Neurology, 74(7). doi:10.1001/jamaneurol.2017.0566

Publication